Plasma donation plays a crucial role in developing therapies for individuals with rare and serious diseases. In Texas, and across the nation, anyone in good health, aged 18 to 74, weighing at least 110 pounds, can donate plasma, provided they meet specific eligibility and screening requirements. Each donor must complete a medical questionnaire reviewed by CSL staff before donating.
Donation Frequency and Compensation
According to U.S. FDA regulations, eligible donors can donate plasma twice within a seven-day period, ensuring a two-day gap between donations. The Cross Donation Check System (CDCS) helps monitor donation frequencies to comply with these regulations. Donors are compensated for their contributions, which are essential for creating life-saving therapies. Compensation varies based on factors such as the donor’s targeted collection amount, the location of the donation center, and any local incentives in place.
Donation Experience
Donating plasma is generally not painful, with most donors comparing the needle insertion to a slight pinch or bee sting. The initial donation, including a health assessment, takes about 2 to 2.5 hours, while subsequent visits typically last 1 to 1.5 hours.
Plasma Processing and Uses
After collection, plasma undergoes rigorous safety testing. It is frozen and held for 60 days before being shipped for manufacturing, where plasma proteins are separated and purified. These proteins are used to develop therapies for conditions like primary immunodeficiency, hereditary angioedema, and chronic inflammatory demyelinating polyneuropathy (CIDP), as well as acute conditions such as trauma, burns, shock, and certain maternal health complications.
The Importance of Plasma Donations
Plasma-derived therapies are vital, as synthetic substitutes are not available for many conditions. It can take hundreds to thousands of donations to treat a single patient for a year, making each donation a lifeline for those reliant on these therapies.
Original reporting: Community Impact — Richardson — read the source article.
